Xenon Vision

Basic Information

One Progress Blvd, #36
Alachua, FL, 32615

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. NOVEL CAI DERIVATIVES FOR TOPICAL APPLICATION

    Amount: $50,000.00

    IN MORE THAN 50% OF GLAUCOMA PATIENTS INTRAOCULAR PRESSURE (IOP) IS NOT ADEQUATELY CONTROLLED BY SINGLE DRUG THERAPY. OPTIC NERVE DAMAGE ASSOCIATED WITH ELEVATED IOP IS THE LEADING CAUSE OF IRREVERSIB ...

    SBIR Phase I 1991 Department of Health and Human Services
  2. PILOCARPINE PRODRUGS WITH IMPROVED BIOAVAILABILITY

    Amount: $50,000.00

    INTRAOCULAR PRESSURE (IOP) IS NOT ADEQUATELY CONTROLLED BY SINGLE DRUG THERAPY IN MORE THAN 50 PERCENT OF GLAUCOMA PATIENTS. THE DEVELOPMENT OF ADDITIONAL DRUGS TO TREAT GLAUCOMA EITHER ALONE OR IN CO ...

    SBIR Phase I 1990 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government